Since the cholinesterase inhibitors were introduced for treatment of Alzheimer’s disease, thousands of adverse event reports have been submitted to the FAERS and CVARD databases. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.